Healthcare: Regulatory risks on the rise
11 views
Skip to first unread message
Amit shah
Sep 4, 2013, 6:54:31 AM9/4/13
to amitk...@oneindia.in
Healthcare: Regulatory risks on the rise
The US FDA’s announcement to now undertake surprise checks on Indian pharma companies (as opposed to the previous regime of pre-announced checks) has increased the regulatory risks for Indian pharma companies. Also, the recent revelations of non-compliance and fraudulent activities by top pharma companies raise several concerns. What should investors watch out for after these developments? Three reputed experts share their views in this ’Expert Whitepaper‘
The US FDA’s announcement to now undertake surprise checks on Indian pharma companies (as opposed to the previous regime of pre-announced checks) has increased the regulatory risks for Indian pharma companies. Also, the recent revelations of non-compliance and fraudulent activities by top pharma companies raise several concerns. What should investors watch out for after these developments? Three reputed experts share their views in this ’Expert Whitepaper‘
Reply all
Reply to author
Forward
0 new messages